Identification |
Name: | Piperazine,1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)-, hydrochloride(1:2) |
Synonyms: | Piperazine,1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)-, dihydrochloride(9CI); GBR 12909; I 893 |
CAS: | 67469-78-7 |
Molecular Formula: | C28H32 F2 N2 O . 2 Cl H |
Molecular Weight: | 523.49 |
InChI: | InChI=1/C28H32F2N2O.2ClH/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23;;/h1-3,5-6,8-15,28H,4,7,16-22H2;2*1H |
Molecular Structure: |
|
Properties |
Solubility: | DMSO: >5 mg/mL |
Appearance: | white solid |
Biological Activity: | Potent, competitive inhibitor of dopamine uptake (K i = 1 nM for inhibition of striatal dopamine uptake). Has > 100-fold lower affinity for the noradrenalin and 5-HT uptake carriers. Also a potent sigma ligand (IC 50 = 48 nM). Centrally active following systemic administration. |
Color: | white |
Safety Data |
|
|